Medtech Industry Reacts To Biden’s Nomination Of ACA Defender Becerra To Lead HHS
AdvaMed, MDMA laud Becerra’s pick
The president-elect on 7 December named nominees for his health team, including California attorney general Xavier Becerra for HHS secretary. Missing from the list is a nominee for FDA commissioner.
You may also be interested in...
Two new rules put forward by the US HHS could have a chilling effect on future guidance documents and regulations drafted by the FDA and the 27 other agencies and offices the HHS oversees, a policy expert says. This and other stories topped our list of most-read US regulation, policy, quality control and compliance articles in December.
Two physicians experienced in agency affairs and operations, former commissioner David Kessler and former principal deputy commissioner Joshua Sharfstein, are reportedly finalists to head Biden’s FDA.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”